Skip to main content

Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years

Abstract

Objectives

Human papillomavirus (HPV) has been recognized as a major factor for cervical cancer causation. Other factors, relating to reproduction, are also important. This study aims to disentangle the roles of baseline HPV infection, high vaginal parity (defined as having ≥4 vaginal deliveries), and the interaction between the two in predicting cervical cancer risk.

Methods

The authors apply a newly developed causal-pie modeling technique to analyze a cohort of more than 10,000 women conducted in Taiwan with more than 10 years of follow-up. The rate ratios adjusted by age and menopausal status were further modeled by an additive Poisson regression with non-negative parameters. The index of causal-pie weight (CPW) was calculated to indicate the proportion of cervical cancer cases attributable to a particular class of causal pies.

Results

It was found that the CPWs are 36.3 % for baseline HPV infection, 35.6 % for baseline HPV infection and high vaginal parity, and 28.1 % for other factors.

Conclusions

A causal-pie modeling based on a women cohort in Taiwan successfully disentangles the roles of virus factors and reproductive factors at study entry, independently or interactively, on subsequent cervical cancer risk.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Bosch FX, de Sanjose S (2003) Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 31:3–13

    PubMed  Article  Google Scholar 

  2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN (2008), Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr

  3. Taiwan Cancer Registry. Cancer Incidence and Mortality Rates in Taiwan. [Internet]. Available at http://www.bhp.doh.gov.tw/bhpnet/portal/Statistics.

  4. Waggoner SE (2003) Cervical cancer. Lancet 361:2217–2225

    PubMed  Article  Google Scholar 

  5. Munoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19:1–5

    PubMed  Article  CAS  Google Scholar 

  6. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265

    PubMed  Article  CAS  Google Scholar 

  7. Bosch FX, de Sanjose S (2007) The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 23:213–227

    PubMed  Google Scholar 

  8. Steben M, Duarte-Franco E (2007) Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 107:S2–S5

    PubMed  Article  CAS  Google Scholar 

  9. Koutsky LA, Holmes KK, Critchlow CW et al (1992) A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 327:1272–1278

    PubMed  Article  CAS  Google Scholar 

  10. Sherman ME, Lorincz AT, Scott DR et al (2003) Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 95:46–52

    PubMed  Article  Google Scholar 

  11. Woodman CB, Collins S, Winter H et al (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357:1831–1836

    PubMed  Article  CAS  Google Scholar 

  12. Hildesheim A, Herrero R, Castle PE et al (2001) HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84:1219–1226

    PubMed  Article  CAS  Google Scholar 

  13. Castellsague X, Munoz N (2003) Chapter 3: cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20–28

    PubMed  Article  Google Scholar 

  14. Castellsague X, Bosch FX, Munoz N (2002) Environmental co-factors in HPV carcinogenesis. Virus Res 89:191–199

    PubMed  Article  CAS  Google Scholar 

  15. Vaccarella S, Herrero R, Dai M et al (2006) Reproductive factors, oral contraceptives use, and human papillomavirus infection: pooled analysis of the IARC prevalence surveys. Cancer Epidemiol Biomarkers Prev 15:2148–2153

    PubMed  Article  CAS  Google Scholar 

  16. Munoz N, Franceschi S, Bosetti C et al (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet 359:1093–1101

    PubMed  Article  Google Scholar 

  17. Louie KS, de Sanjose S, Diaz M et al (2009) Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries. Br J Cancer 100:1191–1197

    PubMed  Article  CAS  Google Scholar 

  18. Liao SF, Lee WC (2010) Weighing the causal pies in case-control studies. Ann Epidemiol 20:568–573

    PubMed  Article  Google Scholar 

  19. International Agency for Research on Cancer (IARC) (2009) A review of human carcinogens-Part B: biological agents. Lancet 10:321–322

    Google Scholar 

  20. Lin CY, Chao A, Yang YC et al (2008) Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol 42:361–367

    PubMed  Article  CAS  Google Scholar 

  21. Rothman KJ (1976) Causes. Am J Epidemiol 104:587–592

    PubMed  CAS  Google Scholar 

  22. Rothman KJ, Greenland S, Lash TL (eds) (2008) Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia, PA

    Google Scholar 

  23. Skrondal A (2003) Interaction as departure from additivity in case-control studies: a cautionary note. Am J Epidemiol 158:251–258

    PubMed  Article  Google Scholar 

  24. Munoz N, Bosch FX, de Sanjose S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527

    PubMed  Article  Google Scholar 

  25. Schiffman M, Castle PE, Jeronimo J, Rodriquez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370:890–907

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Wen-Chung Lee.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Liao, SF., Lee, WC., Chen, HC. et al. Baseline human papillomavirus infection, high vaginal parity, and their interaction on cervical cancer risks after a follow-up of more than 10 years. Cancer Causes Control 23, 703–708 (2012). https://doi.org/10.1007/s10552-012-9939-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-012-9939-4

Keywords

  • Human papillomavirus
  • Vaginal parity
  • Cervical cancer
  • Interaction
  • Causal model
  • Epidemiologic methods